Page 1

Quarterly Statement for Q1 2021 December 1 , 2020 , to February 28 , 2021 Gerresheimer enjoys positive start to the new financial year 2021 - Organic revenue growth of 3.1 % in core business - High Value Solutions start the new financial year very positively , focus on Biological Solutions pays off - Adjusted EBITDA increases organically by 7.0 % in core business - Adjusted earnings per share rise by approximately 33 % to EUR 0.57 Forecast confirmed for the financial year 2021 Contents 2 IFRS figures for the Gerresheimer Group 3 Revenues , adjusted EBITDA and financial position gerresheimer 5 Forecast for 2021 6 Financial Information 11 Additional Information